Author

N. Matsunaga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:benchmarking· 2 Research Focus:drug response / drug discovery· 2 Research Focus:database / resource· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Chatterjee· 1 shared A. Garcia-Sastre· 1 shared A. Hirabayashi· 1 shared A. I. Su· 1 shared A. Ojida· 1 shared A. Rubanov· 1 shared A. Sato· 1 shared B. Tornimbene· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Chatterjee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistrybioRxivJun 5, 2022

Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for SARS-CoV-2 3CL Protease

Y. Hirose, N. Shindo, M. Mori…·A. Ojida

The paper identifies a new class of covalent inhibitors for SARS-CoV-2 3CL protease with chlorofluoroacetamide warhead, showing potent antiviral activity comparable to nirmatrelvir.

DOI 10.1021/acs.jmedchem.2c01081

proteomicsexperimental assay

𝕏 PostBluesky

MicrobiologyPLOS ONEPeer-reviewedJun 26, 2020

Comparison of de-duplication methods used by WHO Global Antimicrobial Resistance Surveillance System (GLASS) and Japan Nosocomial Infections Surveillance (JANIS) in the surveillance of antimicrobial resistance

T. Kajihara, K. Yahara, J. Stelling…·K. Shibayama

This study compares de-duplication methods from WHO GLASS and JANIS systems for AMR surveillance, finding small differences in patient counts and resistance percentages for E. coli.

DOI 10.1371/journal.pone.0228234

experimental assaybenchmarking

𝕏 PostBluesky

MicrobiologybioRxivPreprintApr 16, 2020

A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals

L. Riva, S. Yuan, X. Yin…·S. Chanda

This study identifies 30 known drugs that inhibit SARS-CoV-2 replication, with six showing effective concentrations likely to be therapeutic in patients.

DOI 10.1101/2020.04.16.044016

experimental assaydrug response / drug discovery

𝕏 PostBluesky